000 -LEADER |
fixed length control field |
01787nam a22002777a 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
IN-MiVU |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20190820111651.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
fixed length control field |
m|||||o||d| 00| 0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr uuu---uuuuu |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
180412s2009 xxu||||go|||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780511565069 ( e-book ) |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
MAIN |
Language of cataloging |
eng |
Transcribing agency |
IN-MiVU |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
eng |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.3 |
Item number |
CAR/A |
Edition number |
21 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Cartwright, Terence |
245 00 - TITLE STATEMENT |
Title |
Animal Cells as Bioreactors [ electronic resource ] / |
Statement of responsibility, etc. |
by Terence Cartwright. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Cambridge: |
Name of publisher, distributor, etc. |
Cambridge University Press , |
Date of publication, distribution, etc. |
2009. |
440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
Cambridge Studies in Biotechnology (11) |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Because of their complexity, the new generation of genetically engineered protein drugs can only be made by biotechnological methods, using cultures of animal cells. This book covers all aspects of the technologies needed to turn animal cells into an acceptable and cost-effective tool for drug production. This includes modifying them genetically so that they produce the right product in high yield, getting them to grow reproducibly on an industrial scale, and extracting the required product from them. It also covers biological safety issues, and the verification of the chemical and biological nature of the protein drug produced. The work covers developments in all of these areas and how they all need to be integrated for the design of an effective biotechnological production process. It therefore provides a comprehensive guide to this area of biotechnology. |
650 10 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cell Biology and Developmental Biology |
650 10 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Microbiology and Immunology |
650 10 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Life Sciences |
655 #4 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Electronic books |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://doi.org/10.1017/CBO9780511565069">https://doi.org/10.1017/CBO9780511565069</a> |
Link text |
https://doi.org/10.1017/CBO9780511565069 |
Public note |
View to click |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Koha item type |
E-Book |